Amelioration of Non-Selective Endothelin Receptor Antagonist (CPU0213) on Vascular Activity of Septic Shock Mice/rats Induced by Cecal Ligation and Puncture

HE Hai-bo,YUAN Sheng-hua,DAI De-zai,JI Min
DOI: https://doi.org/10.3321/j.issn:1003-3734.2006.11.007
2006-01-01
Abstract:Objective: To assess the amelioration of a non-selective endothelin (ETA/ETB) receptor antagonist CPU0213 on vascular activity of septic shock mice/rats induced by cecal ligation and puncture (CLP) , and explore its possible mechanism. Methods: In 8 hours after the CLP, mice were subcutaneously administered with CPU0213 (30 mg·kg-1) twice daily for 3 days. The survival rate, peritoneal exudates, indexes of important organs in the 3-day course post the CLP were monitored; MDA and GSH-PX levels in serum, heart and kidney were detected, and the activity of aorta pectoralis were measured. Rats that underwent the same CLP procedure were studied in the plasma endothelin-1 levels and mRNA expression of ETA , ETB receptors of mesenteric blood vessel. Results: The survival rate and vascular activity (vascular tension, relaxation and NO bioavailability) of thoracic aorta were significantly decreased, the weight indexes of vital organs and the weight of peritoneal exudates were remarkably increased, and also the abnormal levels of MDA and GSH-PX appeared in mice of model group. The ET-1 levels and mRNA expression of ETA, ETB receptors of mesenteric blood vessel were markedly increased in rats of model group. All of those were reversed significantly after treatment with CPU0213. Conclusion: CPU0213 lessened the impaired vascular activity, abdominal effusion, and increased survival rate by intervening ET-1-reactive oxygen species pathway.
What problem does this paper attempt to address?